Prulifloxacin — CAS 123447-62-1 API Manufacturer & Supplier in India

Prulifloxacin is a prodrug fluoroquinolone antibiotic that is converted in vivo to its active metabolite ulifloxacin. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. It demonstrates broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms, particularly for urinary and respiratory tract infections.

• Treatment of uncomplicated and complicated urinary tract infections
• Management of lower respiratory tract infections
• Acute bacterial exacerbations of chronic bronchitis
• Skin and soft tissue infections caused by susceptible organisms

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support